Welcome to the third issue of the Bang & Olufsen Medicom newsletter!

 In this edition you can read about:

    New Inhaler to be launched at upcoming EASD conference...

    B&O Medicom and AstraZeneca sign new agreement...

    Latest news on a new data capture monitoring device...

    Scroll down the page or print out this document for these stories and more....

The European Association for the Study of Diabetes (EASD) conference 2006 will be held in Copenhagen from the 14-16 September. Bang & Olufsen Medicom will unveil a new breath-actuated inhaler with a novel design and integrated dose counter. The new inhaler will be available for viewing at the Bang & Olufsen Medicom booth, located near the auditorium entrance at Hall B3 - 002B.

The inhaler can be used for a variety of medications and will have a unique design that is user-friendly and easy to use.

In addition visitors to the booth will also be allowed to view the new injection pen cap prototype concept which allows patients to track and trace their injection doses. Come visit us and you could win a set of Bang & Olufsen earphones. For more information you can contact: Medicom

It has been a successful end to our financial year. Recently, Bang & Olufsen’s annual report has been launched, and B&O Medicom has posted turnover is in line with expectations – up 14 million DKK on the past year. Bang & Olufsen Medicom’s turnover for 2005/2006 was 198 million DKK versus 184 million DDK the previous year. The result this year before tax was 13 million DKK.

For more information on the results you can read the latest press release and report.

We have entered into an agreement with AstraZeneca AB on the development of a new patient monitor that measures patient compliance. The companies have signed the agreement to develop an electronic device for that will be used in clinical studies. The device will be designed to register if patients take their medication correctly – and thereby measure patient compliance. Details of the agreement are confidential.

For the press release related to the agreement you can click here...

Bang & Olufsen Medicom will shortly launch a new data capture version of the Helping Hand, tablet reminder device. The new device will be able to record the user's tablet taking routine. Afterwards the device can be connected to a computer via a USB cable and the user's behaviour can be read via a special software.

The device will be useful in clinical trial recordings of patient behaviour and in monitoring chronically ill patients who need to take their medication on a regular basis.

The device is expected to be on the market by end of October.

For more information about this device you can email Medicom.

The collaboration between Bespak and B&O Medicom continues to go from strength to strength regarding the AAI (Assist Actuated Inhaler) which we will jointly co-produce and co-promote.

The new collaboration allows the parties to jointly deliver the device in a customised version to clients with high quality valve mechanisms and rapid large scale production.

The latest venture has also produced three new versions of the AAI, the device can be developed with a maximum programme of up to more than 209 doses (including test shots). Although it is expected that 120 dose counter will be the main version there is also the possiblity of a 60 dose inhaler version.

For more information you can contact Medicom or click on this link.

Increasing Product Utilisation through Improved Patient Communication Strategies: October 23 - 24, 2006 * Brussels, Belgium

Bang & Olufsen Medicom is a sponsor of CBI Patient Compliance event and will be speaking at the event on the topic of "Challenges for successful implementation of adherence enhancing interventions".  Attendees will hear how increasing evidence shows that investing in the behavioural dimension of chronic illness management including the development and implementation of adherence enhancing interventions is an important pathway to improve outcomes in chronically ill patients.      

          The 2006 conference presents strategies for effectively implementing successful compliance programmes where patients take ownership in improving their health and adherence. More information....

The award-winning 3MTM LittmannR E3000 electronic stethoscope was launched in Japan last month. The stethoscope features a unique ANR technology (Ambient Noise Reduction) which filters out surrounding sound by 75% making it easier for physicians to diagnose difficult to hear heart and lung sounds. The amplification of specific sounds is proven in tests carried out by 3M to be 18 times greater than acoustic stethoscopes.

More information on the E3000 stethoscope.

Bang & Olufsen Medicom thank you for your time in reading our newsletter and would like to offer you the opportunity to have a free sample of our award-winning Helping HandTM tablet reminder device posted to you.

We are happy to provide a sample to potential pharmaceutical clients, members of the media or patient groups, please email:medicom@bang-olufsen.dk

Don't forget to add:

¤ Your Name

¤ The company/ association you represent

¤ Your Full Address

¤ Your Email

¤ Your Telephone number

Bang & Olufsen Medicom designs, develops and co-markets drug delivery solutions to increase patient compliance. Medicom is an award-winning supplier of medical devices that have the goal of helping remind the patient when to take their medication and keep track of the medication in general. We have devised this newsletter to keep you informed about our latest news, product developments and event participation. Follow this link for information on B&O Medicom. 

Bang & Olufsen Medicom a/s

We hope you will enjoy the newsletter which will be issued every quarter. If you have any questions on this newsletter or would like to suggest a topic we would like to hear from you please email the Editor.

Subscribe a colleague / Unsubscribe

We have taken the liberty of adding you automatically to this email distribution list. If you wish to add another colleague or should you wish to unsubscribe (we hope not!) - you can do so by visiting this link: http://www.medicompliance.biz/sw1690.asp